BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23971625)

  • 1. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey.
    Barnes N; Calverley PM; Kaplan A; Rabe KF
    BMC Pulm Med; 2013 Aug; 13():54. PubMed ID: 23971625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care.
    Müllerová H; Lu C; Li H; Tabberer M
    PLoS One; 2014; 9(1):e85540. PubMed ID: 24427316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of quality of life with the chronic obstructive pulmonary disease assessment test in chronic obstructive pulmonary disease and the effect of dyspnea on disease-specific quality of life in these patients.
    Okutan O; Tas D; Demirer E; Kartaloglu Z
    Yonsei Med J; 2013 Sep; 54(5):1214-9. PubMed ID: 23918572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease and exacerbations: clinician insights from the global Hidden Depths of COPD survey.
    Barnes N; Calverley PM; Kaplan A; Rabe KF
    Curr Med Res Opin; 2014 Apr; 30(4):667-84. PubMed ID: 24256026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of an Aclidinium Bromide Treatment for 12 Weeks or Longer in Patients with Moderate-To-Severe COPD: A Meta-Analysis.
    Zou Y; Xiao J; Yang DH; Li J; Chen Q
    COPD; 2016 Aug; 13(4):499-508. PubMed ID: 26846588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
    Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
    BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
    Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of night-time symptoms in COPD: a real-world study in five European countries.
    Price D; Small M; Milligan G; Higgins V; Gil EG; Estruch J
    Int J Chron Obstruct Pulmon Dis; 2013; 8():595-603. PubMed ID: 24348032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of health-related quality of life worsening in patients with chronic obstructive pulmonary disease at one year.
    Liang L; Lin Y; Yang T; Zhang H; Li J; Wang C
    Chin Med J (Engl); 2014; 127(1):4-10. PubMed ID: 24384416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes.
    Hernandez P; Balter M; Bourbeau J; Hodder R
    Respir Med; 2009 Jul; 103(7):1004-12. PubMed ID: 19269150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency of medical record reporting of a set of indicators for proactive palliative care in patients with chronic obstructive pulmonary disease.
    Duenk RG; Verhagen SC; Janssen MA; Dekhuijzen RP; Vissers KC; Engels Y; Heijdra Y
    Chron Respir Dis; 2017 Feb; 14(1):63-71. PubMed ID: 27872166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
    Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
    J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical Modeling of Disease Progression for Chronic Obstructive Pulmonary Disease Using Data from the ECLIPSE Study.
    Exuzides A; Colby C; Briggs AH; Lomas DA; Rutten-van Mölken MPMH; Tabberer M; Chambers M; Muellerova H; Locantore N; Risebrough NA; Ismaila AS; Gonzalez-McQuire S
    Med Decis Making; 2017 May; 37(4):453-468. PubMed ID: 26449490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and management of chronic breathlessness in COPD in a tertiary care center.
    Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F;
    BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?
    Caillaud D; Chanez P; Escamilla R; Burgel PR; Court-Fortune I; Nesme-Meyer P; Deslee G; Perez T; Paillasseur JL; Pinet C; Jebrak G; Roche N;
    Allergy; 2017 Jan; 72(1):137-145. PubMed ID: 27501862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.